Seeking Alpha

"The decline of the order intake was very disappointing," says analyst Jos Versteeg referring to...

"The decline of the order intake was very disappointing," says analyst Jos Versteeg referring to weakness in Philips' (PHG) healthcare unit which the company says should still experience 3-4% growth for the full year (Q1 results). When asked on the call how confident the company is about delivering on that prediction, CEO Frans van Houten says "more traction in Northern Europe" and "increased orders on the government side" in the U.S. make him absolutely confident in the healthcare unit's "resiliency" in the eurozone and positioning in the U.S. once "the dust settles" on healthcare reform. (transcript)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector